CEBPA and breast carcinoma: In breast cancer cells, PRMT1 can interact with CCAAT/enhancer-binding protein alpha (C/EBPα), a member of the leucine zipper transcription factor family, and methylate it at both R35 and R156 (the most critical sites) residues.